[PDF] Top 20 Treatment of stage IV gastric cancer with induction chemotherapy using S 1 and cisplatin followed by curative resection in selected patients
Has 10000 "Treatment of stage IV gastric cancer with induction chemotherapy using S 1 and cisplatin followed by curative resection in selected patients" found on our website. Below are the top 20 most common "Treatment of stage IV gastric cancer with induction chemotherapy using S 1 and cisplatin followed by curative resection in selected patients".
Treatment of stage IV gastric cancer with induction chemotherapy using S 1 and cisplatin followed by curative resection in selected patients
... of patients who received treatment, and there was no control group for ...26 patients had peritoneal ...10 patients for various ...16 patients by imaging by a specialist in radiological ... See full document
7
The impact and optimal indication of non curative gastric resection for stage IV advanced gastric cancer diagnosed during surgery: 10 years of experience at a single institute
... Gastric cancer is the second leading cause of cancer- related deaths in Japan ...R0 resection and negative lymph nodes are the most important factors for long-term ...tric cancer ... See full document
6
Intra-arterial chemotherapy improved survival of stage 2–3 gallbladder cancer after curative resection
... intravenous chemotherapy (IVC) following 2 courses of IAC (ART group), and 39 underwent 6 courses of IVC (SYS ...as stage 2–3 GBC, no previous anticancer treatment, Karnofsky performance score$70, ... See full document
5
Relevance of Surgery in Stage IV Gastric Carcinoma
... of Stage IV gastric cancer was ...the treatment of gastric cancer (3rd Edi- tion), the treatments for Stage IV gastric cancer are che- ... See full document
10
<p>Comparison of Docetaxel + Oxaliplatin + S-1 vs Oxalipatin + S-1 as Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer: A Propensity Score Matched Analysis</p>
... D2 resection with TLND of at least 15 should be the standard for upfront radical ...that patients with D2 resection and TLND of 15 or more have better survival compared with those with D1 and TLND of ... See full document
13
Evaluating the benefits of neoadjuvant chemotherapy for advanced epithelial ovarian cancer: a retrospective study
... R0 resection at PDS was as- sociated with the best ...< 1 cm provides a smaller but still significant benefit for pa- tients with ...these patients, aggressive surgical procedures should be ... See full document
8
<p>Hepatic Arterial Infusion Combined with Systemic Chemotherapy for Patients with Extensive Liver Metastases from Gastric Cancer</p>
... major treatment strategy. However, the ef fi cacy of systemic chemotherapy in patients with LMGC is not satisfactory, demonstrating ORR of 50 – ...comprehensive treatment meth- ...of ... See full document
6
Development and validation of a prognostic nomogram for predicting early recurrence after curative resection of stage II/III gastric cancer
... postoperative treatment as planned, even in recent prospective large- scale randomized controlled studies ...adjuvant chemotherapy has been identified to independ- ently predict poor outcomes for ... See full document
10
Preoperative chemotherapy with docetaxel, cisplatin, and 5-fluorouracil for locally advanced esophageal carcinosarcoma: a case report and review of the literature
... the stage, prognosis, and efficacy of preoperative therapy in squamous cell carcinoma ...preoperative chemotherapy in the pathological evaluation as shown by FDG-PET scans, which showed no FDG uptake by the ... See full document
7
Postoperative prophylactic hepatic arterial infusion chemotherapy for stage III colorectal cancer: a retrospective study
... of stage III CRC patients who underwent radical resection in the First People’s Hospital affiliated to Huzhou University Medical College between 2002 and 2008 were enrolled in this retrospective ... See full document
6
Application of Regional Arterial Infusion Chemotherapy in Advanced Gastric Cancer
... delivering chemotherapy drugs to tumor lesions, thereby improving the therapeutic responses and reducing the adverse effects of the ...AGC stage and improve the rate of radical ...Postoperative ... See full document
12
<p>Peripheral Blood Platelet–Lymphocyte Ratio Is Good Predictor of Chemosensitivity and Prognosis in Gastric Cancer Patients</p>
... one chemotherapy regimen (mDCS therapy) evaluated the correlation with peripheral in fl ammation/immune ...for gastric cancer treatment ...In gastric cancer, overall survival also ... See full document
9
A retrospective study of concurrent chemoradiotherapy plus S-1 adjuvant chemotherapy on curative effect for treatment of patients with N3 stage nasopharyngeal carcinoma
... of S-1, which is more conducive to the suppression of tumor proliferation after ...concurrent chemotherapy) and general-fading group (the rest of all), and there were no differences in the OS, DMFS, ... See full document
7
Original Article Prognostic value of C-reactive protein/albumin ratio in patients receiving first-line palliative chemotherapy with unresectable stage IV gastric cancer
... (Tables 1 and 2) were excluded as well as those who underwent previous surgery, radio- therapy, or chemotherapy at other ...excluded patients lost to follow-up as well as patients who died of ... See full document
12
Metachronous solitary splenic metastasis arising from early gastric cancer: a case report and literature review
... Background: The metastasis of malignant tumors to the spleen is rare, and only a small percentage of cases can be treated surgically, as splenic metastases generally occur in the context of multivisceral metastatic ... See full document
6
Systemic immune-inflammation index, thymidine phosphorylase and survival of localized gastric cancer patients after curative
... Several studies may give several explanations for our results: (1) Cytotoxic lymphocytes and other lymphocytes play a fundamental role in cell-mediated immunologic destruction of cancer cells [28]. ... See full document
9
Effects of delay in adjuvant chemotherapy on survival in patients undergoing curative resection for rectal cancer and the risk factors associated with delay in chemotherapy
... Adjuvant Treatment for Colon Cancer Thierry André, ...Adjuvant Treatment of Colon Cancer (MOSAIC) Investigators N Engl J Med 2004 and 350:2343-2351June 3, 2004DOI: ... See full document
96
The Outcome of Treatment for Patients with Borrmann Type 4 Advanced Gastric Cancer
... advanced gastric cancer into four gross types ...advanced gastric cancer was defined as follows: diffuse cancer, ulcers are almost invisible, and an ill-defined ...the treatment ... See full document
10
Short Hydration in Chemotherapy with Cisplatin plus S 1 for Advanced or Recurrent Gastric Cancer: A Retrospective Study
... Another study compared 30 patients with gastric cancer, lung cancer, and the urothelial cancer who received outpatient chemotherapy containing CDDP ≥60 mg/m2/cycle with short hydration r[r] ... See full document
8
Prognostic impact of KRAS mutant type and MET amplification in metastatic and recurrent gastric cancer patients treated with first-line S-1 plus cisplatin chemotherapy
... in patients with metastatic and recurrent GC treated with ...promote cisplatin- resistant cancer ...mutant cancer cell lines [18, ...lung cancer [21, ...lung cancer [23, ... See full document
9
Related subjects